We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,584 hedge funds and large institutions have $251B invested in Johnson & Johnson in 2018 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 1,107 increasing their positions, 1,110 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 69

18% more funds holding in top 10

Funds holding in top 10: 553651 (+98)

14% more capital invested

Capital invested by funds: $219B → $251B (+$31.6B)

0.08% more ownership

Funds ownership: 67.58%67.66% (+0.08%)

0% less repeat investments, than reductions

Existing positions increased: 1,107 | Existing positions reduced: 1,110

0% less funds holding

Funds holding: 2,5932,584 (-9)

26% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $2.02B

Holders
2,584
Holders Change
-9
Holders Change %
-0.35%
% of All Funds
59.06%
Holding in Top 10
651
Holding in Top 10 Change
+98
Holding in Top 10 Change %
+17.72%
% of All Funds
14.88%
New
84
Increased
1,107
Reduced
1,110
Closed
69
Calls
$1.49B
Puts
$2.02B
Net Calls
-$525M
Net Calls Change
-$83.1M
Name Holding Trade Value Shares
Change
Change in
Stake
CG
1201
Caprock Group
Idaho
$4.96M -$185K -1,395 -4%
IC
1202
Intersect Capital
California
$4.95M -$18.5K -139 -0.4%
GIA
1203
GHP Investment Advisors
Colorado
$4.93M -$124K -930 -3%
TI
1204
TT International
United Kingdom
$4.93M
CHC
1205
City Holding Co
West Virginia
$4.93M +$226K +1,698 +5%
ACM
1206
Argyle Capital Management
Pennsylvania
$4.92M
PC
1207
Palo Capital
California
$4.92M -$102K -769 -2%
CGT
1208
Capital Guardian Trust
California
$4.92M -$4.63M -34,856 -49%
RCAG
1209
Rehmann Capital Advisory Group
Michigan
$4.92M +$34K +256 +0.7%
SFM
1210
Signature Financial Management
Virginia
$4.91M -$10.1K -76 -0.2%
FBT
1211
First Bankers Trust
Kentucky
$4.9M +$18.3K +138 +0.4%
PT
1212
Plimoth Trust
Massachusetts
$4.89M +$7.97K +60 +0.2%
NDSI
1213
Newman Dignan & Sheerar Inc
Rhode Island
$4.89M +$52.9K +398 +1%
Impax Asset Management Group
1214
Impax Asset Management Group
United Kingdom
$4.89M +$4.7M +35,370 New
HPIA
1215
Hamilton Point Investment Advisors
North Carolina
$4.88M +$8.64K +65 +0.2%
SLA
1216
Silver Lake Advisory
Utah
$4.88M +$70.6K +531 +2%
AL
1217
Aspiriant LLC
California
$4.87M -$1.54M -11,567 -25%
FAM
1218
Fred Alger Management
New York
$4.85M -$122K -920 -3%
Cetera Investment Advisers
1219
Cetera Investment Advisers
Illinois
$4.84M +$259K +1,949 +6%
RHFI
1220
Reilly Herbert Faulkner III
$4.83M +$55.5K +418 +1%
DAM
1221
Delta Asset Management
Tennessee
$4.82M +$506K +3,811 +12%
Verition Fund Management
1222
Verition Fund Management
Connecticut
$4.8M +$1.16M +8,739 +34%
AC
1223
Abbrea Capital
California
$4.8M -$31.6K -238 -0.7%
JWM
1224
JGP Wealth Management
Oregon
$4.78M -$266 -2 -0%
LCM
1225
Logan Capital Management
Pennsylvania
$4.77M -$266 -2 -0%

JNJ Hedge Fund Activity: Q3 2018 in Review

2,584 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2018, worth a combined $251B — up 14% from $219B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new JNJ positions and 69 closed out — a net gain of 15 holders — while 1,107 added to existing stakes and 1,110 trimmed.

The largest buyer was Capital International Investors, adding an estimated $2.49B. The largest seller was Capital World Investors, cutting an estimated $2.21B.

  • 2,584 institutional investors held Johnson & Johnson (JNJ) as of Q3 2018, down from 2,593 in Q2 2018.
  • Funds reported $251B of Johnson & Johnson stock for Q3 2018, up 14% quarter-over-quarter.
  • 84 funds opened new Johnson & Johnson positions in Q3 2018 and 69 closed out, a net change of +15 holders.
  • The largest Johnson & Johnson buyer in Q3 2018 was Capital International Investors, an estimated $2.49B added.
  • The largest Johnson & Johnson seller in Q3 2018 was Capital World Investors, an estimated $2.21B sold.

Based on aggregated 13F filings for Q3 2018.